CROs/Service Providers

AMRI announces additional actions to streamline operations

Monday, January 9, 2012 01:40 PM

Albany Molecular Research (AMRI) took steps in the fourth quarter of 2011 to align the business to current and expected market conditions, including reducing the company’s workforce, right size capacity and reduce operating costs for 2012.

More... »

Alexion to acquire Enobia Pharma for $610 million

Tuesday, January 3, 2012 01:39 PM

Alexion Pharmaceuticals and Enobia Pharma have signed a definitive agreement under which Alexion will acquire 100% of the capital stock of Enobia. Enobia is a private biopharmaceutical company based in Montreal, Canada and Cambridge, Massachusetts, which is focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.

More... »

Quintiles forms Digital Patient Unit

Tuesday, January 3, 2012 01:14 PM

Quintiles has formed a Digital Patient unit which brings together the company’s online communities and digital expertise to directly engage patients.

More... »

Baxter, Momenta enter $33 million biosimilar development agreement

Friday, December 23, 2011 12:29 PM

Baxter International and Momenta Pharmaceuticals have entered into a global collaboration to develop and commercialize follow-on biologic products, also known as biosimilars. Biosimilars replicate existing, branded biologics used in the treatment of a variety of diseases including cancer, autoimmune disorders and other chronic conditions. With this collaboration, Baxter will leverage its leading clinical development and biologic manufacturing expertise, global leadership in sterile injectables and global commercial capabilities, while Momenta will provide its expertise in high-resolution analytics, characterization, and product and process development.

More... »

AMRI to reduce U.S. workforce

Friday, December 23, 2011 10:17 AM

AMRI will reduce the company's workforce, right size capacity, and reduce operating costs in 2012. The actions will better align the business to current and expected market conditions and are expected to improve the company's overall cost competitiveness and increase cash flow generation.

More... »

Medco shareholders approve merger with Express Scripts

Thursday, December 22, 2011 12:48 PM

More... »

Intarcia, Quintiles form strategic partnership

Thursday, December 22, 2011 12:38 PM

More... »

Clinigene, Pacific Biomarkers collaborate

Wednesday, December 21, 2011 11:24 AM

Clinigene International and Pacific Biomarkers have formed a collaborative agreement to address the specialty biomarker and high-end clinical trial laboratory needs of the global pharmaceutical and biotechnology industry.

More... »

Warnex to sell analytical services division

Wednesday, December 21, 2011 11:10 AM

Warnex has entered into an agreement with a private company to sell its wholly-owned analytical services division, which provides pharmaceutical and biotechnology companies with a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Closing of this transaction will take place upon the execution of definitive documentation, which is expected to occur on or about January 15, 2012

More... »

Marken continues expansion with Buenos Aires facility

Tuesday, December 20, 2011 01:39 PM

Marken continues their expansion of services in Latin America, by augmenting their new purpose-built Buenos Aires facility.

More... »